PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930046
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930046
Point-of-Care Coagulation Testing Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of point-of-care coagulation (POCC) testing devices Market
The global point-of-care coagulation (POCC) testing devices market has emerged as a critical segment within diagnostic technologies due to the increasing need for rapid and accurate coagulation assessment. These devices enable clinicians to evaluate a patient's coagulation status in real time, supporting timely clinical decisions in emergency care, surgical procedures, and anticoagulation therapy monitoring.
According to the report, the global POCC testing devices market was valued at USD 2.01 billion in 2025. The market is projected to expand to USD 2.16 billion in 2026 and further reach USD 3.88 billion by 2034, registering a compound annual growth rate (CAGR) of 7.62% during the forecast period from 2026 to 2034. This growth is primarily driven by the rising prevalence of bleeding disorders, technological advancements in point-of-care diagnostics, and increasing adoption of home-based healthcare solutions.
Market Drivers and Growth Factors
One of the key drivers fueling market growth is the increasing patient pool suffering from bleeding disorders, including hemophilia, venous thromboembolism, and coagulation abnormalities associated with aging. The growing geriatric population is particularly vulnerable to coagulation imbalance, thereby increasing demand for portable and easy-to-use testing devices.
In addition, technological advancements in POCC testing devices have significantly improved accuracy, usability, and turnaround time. Market players are launching advanced systems capable of delivering rapid results at the bedside or in homecare settings. The rising demand for home healthcare solutions has further accelerated adoption, as patients undergoing long-term anticoagulation therapy prefer self-monitoring devices to avoid frequent hospital visits.
Another contributing factor is the improvement in healthcare infrastructure in emerging markets, where governments are investing heavily in expanding diagnostic services, especially in community healthcare centers and small clinics.
Market Restraints and Challenges
Despite strong growth prospects, the market faces notable challenges. The high cost of POCC testing devices, along with recurring expenses related to maintenance and consumables, restricts adoption in price-sensitive and emerging economies. Limited reimbursement policies and stringent regulatory requirements for home-based testing devices also hinder market penetration.
Furthermore, competition from traditional laboratory coagulation testing remains a challenge, as conventional analyzers are widely trusted for their comprehensive testing capabilities. A lack of awareness and insufficient training among healthcare professionals regarding the correct use of POCC devices can also lead to underutilization and misinterpretation of results.
Segmentation Insights
By device type, anticoagulation monitoring devices dominated the market, accounting for 79.64% of the total market share in 2026, supported by increasing regulatory approvals and widespread use in monitoring PT/INR levels. Meanwhile, viscoelastic coagulation monitoring devices are expected to witness the fastest growth during the forecast period due to their ability to assess all stages of clot formation in real time.
By end user, the hospitals and clinics segment led the market with a 63.85% share in 2026, driven by the growing number of complex surgical procedures requiring immediate coagulation assessment. The homecare settings segment is anticipated to grow at the highest CAGR due to rising patient preference for self-monitoring solutions.
Regional Outlook
North America dominated the global market in 2025, accounting for USD 0.85 billion, supported by the strong presence of leading manufacturers, high prevalence of bleeding disorders, and favorable regulatory approvals. Europe held the second-largest share due to the introduction of advanced coagulation analyzers in hospitals. The Asia Pacific region is expected to grow at the highest CAGR, driven by increasing awareness, regulatory approvals, and expanding healthcare infrastructure in countries such as China, India, and Japan.
Competitive Landscape
The market is semi-consolidated, with major players including F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers AG, Werfen, Haemonetics Corporation, and Medtronic. These companies focus on strategic collaborations, regulatory approvals, and product innovations to strengthen their market position.
Conclusion
In conclusion, the global point-of-care coagulation (POCC) testing devices market is poised for sustained growth, rising from USD 2.01 billion in 2025 to USD 3.88 billion by 2034. The increasing burden of bleeding disorders, growing demand for rapid diagnostic solutions, and expansion of home-based healthcare are key factors shaping market expansion. While high costs and competition from traditional laboratory testing pose challenges, ongoing technological advancements and strategic initiatives by leading players are expected to enhance adoption and drive long-term market growth across developed and emerging regions.
Growth rate CAGR of 7.62% from 2026-2034
Segmentation
By Device Type
- Anticoagulation Monitoring Devices
- Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices
- Activated Clotting Time (ACT)
- Activated Partial Thromboplastin Time (aPTT)
- Platelet Function Monitoring Devices
- Viscoelastic Coagulation Monitoring Devices
- Thromboelastography (TEG)
- Rotational Thromboelastometry (ROTEM)
- Others
By End User
- Hospitals & Clinics
- Homecare Settings
- Others
By Region
- North America (by Device Type, by End User, by Country)
- U.S.
- Canada
- Europe (by Device Type, by End User, by Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (by Device Type, by End User, by Country/Sub-region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of the Asia Pacific
- Latin America (by Device Type, by End User, by Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (by Device Type, by End User, by Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Prevalence of Key Coagulation Diseases- For Key Countries, 2025
- 4.2. Recent Advancements in the Point of Care (POC) Coagulation Testing
- 4.3. Regulatory Scenario - For Key Countries
- 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 4.5. Impact of COVID-19 on the Market
5. Global Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Device Type
- 5.1.1. Anticoagulation Monitoring Devices
- 5.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 5.1.1.2. Activated Clotting Time (ACT)
- 5.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 5.1.2. Platelet Function Monitoring Devices
- 5.1.3. Viscoelastic Coagulation Monitoring Devices
- 5.1.3.1. Thromboelastography (TEG)
- 5.1.3.2. Rotational Thromboelastometry (ROTEM)
- 5.1.4. Others
- 5.1.1. Anticoagulation Monitoring Devices
- 5.2. Market Analysis, Insights and Forecast - By End User
- 5.2.1. Hospitals & Clinics
- 5.2.2. Homecare
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
6. North America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Device Type
- 6.1.1. Anticoagulation Monitoring Devices
- 6.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 6.1.1.2. Activated Clotting Time (ACT)
- 6.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 6.1.2. Platelet Function Monitoring Devices
- 6.1.3. Viscoelastic Coagulation Monitoring Devices
- 6.1.3.1. Thromboelastography (TEG)
- 6.1.3.2. Rotational Thromboelastometry (ROTEM)
- 6.1.4. Others
- 6.1.1. Anticoagulation Monitoring Devices
- 6.2. Market Analysis, Insights and Forecast - By End User
- 6.2.1. Hospitals & Clinics
- 6.2.2. Homecare
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By Country
- 6.3.1. U.S.
- 6.3.2. Canada
7. Europe Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Device Type
- 7.1.1. Anticoagulation Monitoring Devices
- 7.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 7.1.1.2. Activated Clotting Time (ACT)
- 7.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 7.1.2. Platelet Function Monitoring Devices
- 7.1.3. Viscoelastic Coagulation Monitoring Devices
- 7.1.3.1. Thromboelastography (TEG)
- 7.1.3.2. Rotational Thromboelastometry (ROTEM)
- 7.1.4. Others
- 7.1.1. Anticoagulation Monitoring Devices
- 7.2. Market Analysis, Insights and Forecast - By End User
- 7.2.1. Hospitals & Clinics
- 7.2.2. Homecare
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Spain
- 7.3.5. Italy
- 7.3.6. Scandinavia
- 7.3.7. Rest of Europe
8. Asia Pacific Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Device Type
- 8.1.1. Anticoagulation Monitoring Devices
- 8.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 8.1.1.2. Activated Clotting Time (ACT)
- 8.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 8.1.2. Platelet Function Monitoring Devices
- 8.1.3. Viscoelastic Coagulation Monitoring Devices
- 8.1.3.1. Thromboelastography (TEG)
- 8.1.3.2. Rotational Thromboelastometry (ROTEM)
- 8.1.4. Others
- 8.1.1. Anticoagulation Monitoring Devices
- 8.2. Market Analysis, Insights and Forecast - By End User
- 8.2.1. Hospitals & Clinics
- 8.2.2. Homecare
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.3.1. Japan
- 8.3.2. China
- 8.3.3. India
- 8.3.4. Australia
- 8.3.5. Southeast Asia
- 8.3.6. Rest of Asia Pacific
9. Latin America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Device Type
- 9.1.1. Anticoagulation Monitoring Devices
- 9.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 9.1.1.2. Activated Clotting Time (ACT)
- 9.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 9.1.2. Platelet Function Monitoring Devices
- 9.1.3. Viscoelastic Coagulation Monitoring Devices
- 9.1.3.1. Thromboelastography (TEG)
- 9.1.3.2. Rotational Thromboelastometry (ROTEM)
- 9.1.4. Others
- 9.1.1. Anticoagulation Monitoring Devices
- 9.2. Market Analysis, Insights and Forecast - By End User
- 9.2.1. Hospitals & Clinics
- 9.2.2. Homecare
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
10. Middle East & Africa Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Device Type
- 10.1.1. Anticoagulation Monitoring Devices
- 10.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
- 10.1.1.2. Activated Clotting Time (ACT)
- 10.1.1.3. Activated Partial Thromboplastin Time (aPTT)
- 10.1.2. Platelet Function Monitoring Devices
- 10.1.3. Viscoelastic Coagulation Monitoring Devices
- 10.1.3.1. Thromboelastography (TEG)
- 10.1.3.2. Rotational Thromboelastometry (ROTEM)
- 10.1.4. Others
- 10.1.1. Anticoagulation Monitoring Devices
- 10.2. Market Analysis, Insights and Forecast - By End User
- 10.2.1. Hospitals & Clinics
- 10.2.2. Homecare
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.3.1. GCC Countries
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Werfen
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. CoaguSense Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Helena Laboratories Corporation
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Medtronic
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Abbott
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Siemens Healthcare AG
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Koninklijke Philips N.V.
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. HemoSonics LLC
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Haemonetics Corporation
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.1. Werfen
List of Tables
- Table 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 5: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 16: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 22: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
- Table 27: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
- Table 28: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
- Table 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2025 & 2034
- Figure 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2025 & 2034
- Figure 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Region, 2025 & 2034
- Figure 5: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
- Figure 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
- Figure 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
- Figure 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
- Figure 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country, 2025 & 2034
- Figure 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country, 2023
- Figure 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
- Figure 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
- Figure 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
- Figure 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
- Figure 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 16: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
- Figure 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
- Figure 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
- Figure 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
- Figure 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
- Figure 21: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 22: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
- Figure 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
- Figure 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
- Figure 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
- Figure 26: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
- Figure 27: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 28: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
- Figure 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
- Figure 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
- Figure 31: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
- Figure 32: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
- Figure 33: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 34: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
- Figure 35: Global Point-of-Care Coagulation (POCC) Testing Devices Market Share (%), By Company, 2023
